HER2 overexpression leads to increased tumor invasiveness proliferation [43], with evidence suggesting that HER2-HER3 heterodimers activate the PI3K–Akt signaling pathway, which plays a key role in metastasis. The gene discussed is ERBB2; the disease is neoplasm.